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The ATR-Chk1 checkpoint pathway is activated by UV-induced DNA lesions and replication stress. Little was known about
the spatio and temporal behaviour of the proteins involved, and we, therefore, examined the behaviour of the ATRIP-ATR and
Rad9-Rad1-Hus1 putative DNA damage sensor complexes and the downstream eﬀector kinase Chk1. We developed assays for the
generation and validation of stable cell lines expressing GFP-fusion proteins. Photobleaching experiments in living cells expressing
these fusions indicated that after UV-induced DNA damage, ATRIP associates more transiently with damaged chromatin than
members of the Rad9-Rad1-Hus1 complex. Interestingly, ATRIP directly associated with locally induced UV damage, whereas
Rad9 bound in a cooperative manner, which can be explained by the Rad17-dependent loading of Rad9 onto damaged chromatin.
Although Chk1 dissociates from the chromatin upon UV damage, no change in the mobility of GFP-Chk1 was observed,
supporting the notion that Chk1 is a highly dynamic protein.
1. Introduction
Eukaryotic cells are continuously threatened by DNA damage
caused by environmental factors and intracellular metabolic
processes. To protect themselves against these potential
threats, cells have developed DNA damage checkpoint and
repair mechanisms, which help to ensure transmission of
an intact genome. Cell cycle checkpoints and DNA repair
mechanisms together determine the ultimate faith of the cell
after suﬀering DNA damage. Activation of the DNA damage
checkpoint involves the activation of transducer kinases
ATR/ATM and subsequently the eﬀector kinases Chk1/Chk2
[1]. So-called mediator proteins, including Claspin and
BRCA1, were additionally discovered, and function either
in the recruitment of substrates to DNA lesions or as
scaﬀolds on which protein complexes are assembled [2, 3].
In response to a variety of DNA damaging agents like UV
light and replication stress, the ATR-mediated checkpoint
pathway is activated. Biochemical data indicates that ATRIP,
in complex with ATR, binds to RPA-coated single stranded
DNA (ssDNA) [4]. Independently, the Rad17-RFC complex
is also recruited to sites of damage. The Rad17-RFC protein
complex facilitates the loading of the Rad9-Rad1-Hus1 (9-1-
1 complex) sliding clamp onto the DNA [5–7]. Subsequently,
TopBP1 is recruited to DNA lesions by binding to the
Rad9 subunit of the 9-1-1 complex, thereby locating near
the ATRIP-ATR heterodimer. Through an interaction with
TopBP1, ATR becomes fully active, resulting in the activation
of eﬀector kinase Chk1 and subsequent checkpoint arrest
[8–10].
Detection of DNA alterations after genotoxic stress is
essential for the survival of cells and gaining more insight
into the early events of the DNA damage response will give
a better understanding of how DNA damage checkpoints
function, how genome stability is achieved, and how cancer
can develop. In recent years, biochemical work has provided
invaluable insight into the requirements, substrates, and
activities of proteins involved in the ATR-mediated check-
point pathway [11–13]. Although the importance for protein
localization after DNA damage induction has been reported
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for proteins involved in the response to double-stranded
breaks (DSBs), not much is known about how the ATR-
Chk1 pathway operates in living cells and moreover, how the
spatio and temporal behaviour of proteins in this pathway
influence the DNA damage response [14, 15]. We set out to
study the behaviour of ATRIP-ATR and 9-1-1 DNA damage
sensor complexes by creating cDNA constructs expressing
GFP- (green fluorescent protein-) tagged proteins in human
cells. The use of GFP-fusion proteins creates advantages over
using standard immunofluorescence techniques as it avoids
fixation methods and antibody artefacts. In addition, GFP-
labelled proteins can be followed in time using live cell
video microscopy. Furthermore, due to the spectral qualities
of GFP and its variants it has become possible to perform
quantitative fluorescent analysis [16–18]. The use of GFP-
labelled proteins opens up a number of new possibilities in
the DNA damage response field. First, the localization GFP-
fusion proteins can be directly followed into DNA damage-
induced nuclear foci. Second, the ability to measure in time
makes it possible to establish an order of events occurring
directly after DNA damage induction. Third, the existence of
multiple spectral GFP-variants allows for the simultaneous
detection of several fluorescently labelled proteins in a single
cell [19–21]. Forth, live cell video microscopy in combination
with GFP-photobleaching experiments can be applied to
quantitatively determine changes in protein mobility in
response to DNA damage. Collectively, these tools help to
increase our understanding of cellular mechanisms involved
in DNA damage response.
The accumulation of DNA damage response proteins at
sites of damage, shown in cells as nuclear foci, is essential
for downstream checkpoint events, although how, is not
yet fully understood [22–24]. Many, if not most, proteins
in the ATR-mediated checkpoint pathway are recruited to
sites of damage into nuclear foci. As a result, a proportion
of the total amount of free proteins becomes immobilized
in these foci due to interactions with either the damaged
chromatin or other proteins at the DNA lesion. To gain more
understanding of the DNA damage-induced behaviour of a
protein, its localization and mobility can be determined. The
DNA damage-induced change in protein mobility has been
studied for several proteins involved in the DNA damage
response, mainly in DNA repair and in response to double
stranded breaks (DSBs) [17, 25–27]. The studies performed
on proteins involved in nucleotide excision repair (NER), for
example, have been important in understanding this DNA
repair process and helped explain some of the phenotypic
characteristics seen in patients that harbour mutations in
proteins in this pathway. This indicates the importance of
these types of studies for research in cancer and related
diseases associated with genome instability [28, 29].
A method was setup for the generation of stable cell
lines expressing GFP-fusion proteins and diﬀerent assays
to validate and characterize GFP-expressing cell lines were
developed. We analyzed the dynamic behaviour of multiple
proteins involved in the ATR checkpoint pathway including
all three components of the 9-1-1 complex, ATRIP, and of
the downstream kinase Chk1. We compared the mobility
changes of these proteins after UV-irradiation and together
the results indicated a distinct dynamic behaviour of the
studied proteins. Whereas eﬀector kinase Chk1 was highly
mobile and did not immobilize upon DNA damage, Rad9
and ATRIP were associated to sites of DNA damage. ATRIP
directly bound to DNA lesions but in a more transient man-
ner than Rad9, which displayed a relatively slow exchange
with damaged chromatin. Together these data demonstrate
the importance of spatio and temporal protein regulation in
the cells response to DNA damage.
2. Materials and Methods
2.1. Cell Culture. U2OS, Hela, and 293T cells were grown
using standard procedures. U2OS and Hela cells stably
expressing eGFP-fusion proteins were grown in standard
medium supplemented with 350–700 μg/mL of G418 (gen-
tamicin).
2.2. Antibodies. Antibodies obtained from commercial
sources were as follows: Orc2 (BD Pharmingen), Grb2
(BD Transduction), RPA (Ab2, Oncogene), Rad9 (Novus),
γH2AX (Upstate), Chk1-pS317 (Cell Signaling), and Chk1
(Abcam). The following antibodies were obtained from
Santa Cruz Biotechnology: CENP-F (H-260), Cyclin A (H-
432), Cyclin B1 (GNS1), Ku86 (C-20), Chk1 (G-4), Rad1 (N-
18), Rad9 (C-20), and ATR (N-19).
Rabbit polyclonal anti-Rad9, anti-Hus1, and anti-GFP
were described before and a kind gift by R. Freire (Tenerife,
Spain) [30, 31]. Rabbit polyclonal anti-ATRIP was a kind gift
by P. M. Reaper (UK) [32].
2.3. Transfection. Plasmid DNA was transfected into cells
using the calcium phosphate transfection method.
siRNA oligonucleotides (Dharmacon Research) were
transfected into cells using Oligofectamine (Invitrogen)
according to the manufacturer’s instructions and as previ-
ously described [33]. Sequences of oligonucleotides were as
follows:
Luc (CGUACGCGGAAUACUUCGAdTdT),
Chk1 (UCGUGAGCGUUUGUUGAACdTdT)
Rad9 (ACCACUAUAGGCAAUGAGGdTdT)
Rad9 3′UTR (CCAAGAACCUGAAGCCUGUUU/
GAAUCCAGCUUUGACCUUUU).
2.4. Colony Survival Assays. Cells were counted and 1000
cells were seeded onto 60 mm diameter dishes whereafter left
for 12 hours to attach. Cells were treated with diﬀerent doses
of UV (5, 10, 15, and 20 J/m2) and incubated for 7–14 days,
after which the colonies were fixed, stained, and counted. All
experiments were performed in triplicate.
2.5. Immunofluorescence. For immunostaining, cells were
fixed in 2% paraformaldehyde containing 0.2% Triton X-
100 for 20 minutes at RT and then permeabilized with 0.1%
Triton X-100 for 5 minutes at RT. Samples were blocked in
1% FCS and immunostained with antibodies as indicated.
For detection of GFP-tagged proteins in U2OS cells, living
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cells were studied or cells were fixed and permeabilized as
above.
Images were made using a Cell Observer fluorescent
microscope equipped with Axiovision software (Zeiss) or
a Confocal Laser Scanning Microscope LSM 510 (Zeiss),
equipped with a 488 nm Ar-laser and a 505–530 nm bandpass
filter for green fluorescence. Red fluorescence was detected
using a 543 nm laser and 560 nm longpass filter. For strip-
FRAP experiments and time lapse imaging after UV laser
induction, GFP-tagged proteins were detected in living cells
using a Confocal Laser Scanning Microscope LSM 510
(Zeiss), equipped with a 488 nm Ar-laser and a 505–530 nm
bandpass filter for green fluorescence.
2.6. Whole Cell Extracts and Cell Fractionation. For whole
cell extracts, cells were washed in cold PBS, after which the
cells were resuspended in Laemmli sample buﬀer (4% SDS,
20% glycerol, 120 mM Tris pH 6.8) and boiled for 5 minutes.
Protein concentrations were determined using the Lowry
protein assay. Chromatin fractionation was performed as
previously described [34, 35].
2.7. Generation of DNA Damage and Photobleaching Tech-
niques. UV-irradiation was performed using a 254 nm UV-
C lamp (Philips) at 20 J/m2 and cells were processed 1
hour posttreatment. Cells were incubated with 5 μg/mL of
aphidicolin (Sigma) for 20 hours prior to processing of
samples. Cells were incubated with 200 nM camptothecin
(Sigma) for 20 hours before fixation. IR (10 Gy) was induced
using a 137Cs source or a linear accelerator (LINAC) and
cells were processed 2 hours after treatment. Local UV
laser induction was performed as previously described [36].
In short, cells were grown on a 25 mm quartz coverslip.
A small area inside the nucleus was exposed for ∼1
second to a 2 mW pulsed (7.8 kHz) diode laser emitting
at 266 nm. Time-lapse images were made every minute
immediately starting after local UV induction. The time
course measurements were normalized to the plateau phase.
Start of UV irradiation was defined as t = 0. Assembly
curves were normalized to 1 and processed as previously
described [26].
In the FRAP experiments, a strip spanning the nucleus
was photobleached for 20 milliseconds using an Ar-laser
(488 nm) at 100% laser intensity, which irreversibly bleaches
all GFP molecules in that area. Subsequently, the redis-
tribution of fluorescence in the strip was monitored by
taking confocal images every 20 milliseconds for a total
of 24 seconds at low laser intensity to avoid further
bleaching. The fluorescence before bleaching (It<0) was set
to 1 and the intensity immediately after bleaching (I0) was
set to 0. The recovery of fluorescence was plotted against
time.
In the FLIP experiments, half of the nucleus was
continuously bleached using an Ar-laser (488 nm) at 50%
laser intensity. Subsequently, the loss of fluorescence in
the unbleached area was monitored taking confocal images
every 10 seconds for a total of 300 seconds at low laser
intensity. The fluorescence before bleaching (It<0) was set to
1. The loss of fluorescence was plotted against time. FLIP-
FRAP experiments were performed as previously described
[33, 37].
3. Results
3.1. Generation of Cell Lines Stably Expressing GFP-Tagged
Proteins. The limitations of conventional fixation methods
were overcome by the introduction of GFP, the green
fluorescent protein derived from Aequorea Victoria, a species
of jellyfish [38, 39]. Through the cloning of the cDNA
encoding GFP, it became possible to fluorescently label
proteins and express them, thereby creating the opportunity
for monitoring proteins in living cells. Diﬀerent fluorescent
versions of the GFP exist such as the red fluorescent
(RFP), yellow fluorescent (YPF), and cyan fluorescent (CFP)
protein, and many more spectral variants have been created
since [40]. The expression of GFP and derivatives itself
in mammalian cells is not harmful although the protein
originates from a diﬀerent species. Nonetheless, labelling of
proteins with (fluorescent) epitopes can potentially influence
the behaviour of the labelled protein. Validation and func-
tional analysis of a GFP-fusion protein construct, therefore,
is essential for the interpretation of experimentally obtained
data.
The amount of fluorescence signal in a cell population
derived from a single cell clone is in principle identical in all
cells and, therefore, comparing fluorescence intensities after
diﬀerent treatments becomes reliable. We setup a method
for the creation, generation, and validation of GFP-fusion
proteins for the purpose of live cell imaging. The approach
is schematically depicted in Figure 1(a) and discussed
below.
3.1.1. Creation of GFP-Tagged Protein Constructs. After the
discovery of GFP and its potential usefulness in biology,
the protein itself became the subject of intensive research.
Certain mutations in the GFP gene lead to diﬀerent spectral
variants and improvements in the protein characteristics,
such as an increase in brightness (fluorescent intensity) and
photo stability [41]. These qualities can be found in, for
example, the GFP variant called “enhanced GFP” (eGFP).
Vectors encoding for eGFP and fluorescent derivates are
commercially available (Clontech) and have been published
[40]. In the studies presented here, we made use of vec-
tors containing eGFP or eGFP with the addition of two
other, nonfluorescent epitopes, namely, an HA- and His-tag
(eGFP will hereafter be referred to as GFP). The additional
epitope creates the possibility to detect the GFP-fusion
protein with antibodies directed against the HA- and/or
His-tags. Additionally, these tags can be used for immuno-
precipitation experiments to identify interaction partner
proteins.
For proper cellular function a protein needs to be folded
correctly upon its expression. Since GFP and the cDNA of
interest encode for two proteins that are attached, proper
protein folding might be influenced by sterical hindrance.
As a possible solution to this problem, adding a small
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Figure 1: Generation of stable cell lines expressing GFP-tagged proteins. (a) Stepwise protocol for stable expression of GFP-fusion proteins in
cells. (b) 293T cells were transfected with GFP-Rad1, Rad1-GFP, or mock transfected, after which cells were lysed and immunoprecipitations
were carried out using anti-GFP antibody. Western blot analysis of the immunoprecipitates using the indicated antibodies. (c) Protein
expression analysis of diﬀerent stable clones. Western blot analysis of whole cell extracts using the indicated antibodies.
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DNA sequence linker in between the sequence encoding
for GFP and the cDNA this can be minimized [38, 42].
In addition, such a linker might help to restore the function-
ality of the protein, as a rigid tag might interfere with, for
example, binding to (endogenous) partners.
In addition to a neomycin resistance cassette for selec-
tion, the GFP vectors contain a CMV promoter that is
compatible with expression in immortalized cells, such as
the human osteosarcoma (U2OS) and epithelial cervical
cancer (Hela) cell lines used in this study. As adding a
tag might influence protein functionality, it is advisable
to construct both N- and C-terminal labelled versions of
the proteins. cDNA was cloned into the GFP-vectors via
PCR and/or restriction enzyme cutting and religating by
T4 DNA ligase, resulting in plasmids encoding an in-
frame sequence of GFP and the cDNA of interest. After
obtaining the right plasmid DNA the functionality of the
GFP-fusion protein was tested by determining the interaction
with its known binding partners. In this way a reasonable
choice can be made to continue with either the N- or C-
terminally tagged version of the protein, or both. After
transient expression of the cDNA encoding the GFP-fusion
protein and the known binding partner, cell extracts were
prepared for immunoprecipitation using antibodies against
GFP. The interaction with the known binding partners was
determined by western blotting. The N- and C-terminally
labelled proteins from the Rad9-Rad1-Hus1 complex were
tested in this manner. Labelling of Rad1 at either site of the
protein did not influence the interaction with endogenous
Hus1 (Figure 1(b)). GFP-labelling of Rad9 at the C-terminus
completely abrogated the interaction with its binding part-
ners whereas Hus1 labelling at the N-terminus decreased
the binding to its partners (data not shown). When binding
partners of a GFP-fusion protein are not known or do
not exist and/or antibodies are not available testing for
functionality must be performed in a diﬀerent manner. Later
in this section, diﬀerent assays that can be used to validate
the function of the GFP-tagged protein in living cells are
described.
3.1.2. Expression of GFP-Tagged Proteins in Human Cells.
After obtaining cDNA encoding a GFP-fusion protein, cells
were transfected to achieve random integration of the
GFP-fusion construct. We used the well studied human
U2OS and Hela cells for the expression of the GFP-
fusion protein since these cells are well-suited for both
live cell imaging and siRNA-mediated downregulation of
proteins. We obtained a transient transfection eﬃciency of
∼70% in both Hela and U2OS cells using the calcium-
phosphate transfection method, whereafter we started with
antibiotic selection. Importantly, multiple copies of the
cDNA can be incorporated in the genome and the site (s)
of integration additionally may create artefacts and influence
cellular behaviour. In human cells this problem can only
be tackled by using retroviral constructs that integrate only
once. To minimize these possible artefacts we only selected
individual clones expressing low amounts of GFP-fusion
proteins.
3.1.3. Selection of GFP-Positive Cells Using an Antibiotic
Selection Marker. To obtain cells that incorporated at least
one copy of the GFP-fusion cDNA we used antibiotic
selection through the neomycin-resistance cassette present in
the GFP vector. To achieve stable integration of the cDNA
in the genome of the transfected cells, cells were seeded in
diﬀerent densities and selected using 700 μg/mL G418 for at
least two weeks, refreshing the medium with antibiotics every
3 days.
3.1.4. FACS Sorting of GFP-Positive Cells. G148 selection
caused cell death of cells that did not integrate the cDNA
construct in their genome. GFP-positive cells were sorted
from the total population by FACS. Approximately 5%–
10% of the cells became GFP-positive after two weeks of
G418 selection. This small percentage is most likely due
to an incorrect integration the GFP-fusion cDNA causing
expression of the only part of the construct including the
G418 resistance cassette. The sorted GFP-positive cells were
replated in diﬀerent dilutions so that single cells could grow
into discrete colonies. Cells were kept in similar conditions
of antibiotic selection as previously used and medium was
refreshed at least twice a week.
3.1.5. Picking of Individual Cell Colonies. After the multipli-
cation of a single cell into a colony of around 50–100 cells,
the colonies were randomly picked under sterile conditions
using an inverted light microscope. At least 24 colonies
were picked for every cell line. The selected colonies were
kept in individual wells and were cultured until completely
confluent, whereafter split into two plates. One plate was
frozen and the other one was used to prepare cell lysates for
expression analysis.
3.1.6. Determining Protein Expression Levels of the GFP-
Fusion. The cell lysates from individual clones were analyzed
by SDS-PAGE and western blotting using antibodies specifi-
cally against the protein of interest and GFP. Expression levels
of the endogenous compared to the GFP-fusion protein was
determined as well as the amount of free GFP or the existence
of degradation products.
3.1.7. Selecting Clones Expressing Relatively Low Amounts of
GFP-Tagged Protein. Clones were selected on the basis of the
following criteria: low expression levels of the GFP-fusion
protein (not higher than that of the endogenous protein)
and the absence of free GFP or other undefined products,
based on the western blotting analysis. A number of 4 clones
that meet these criteria were selected and thawed for further
validation. Clones were cultured in medium containing
350 μg/mL G418 to maintain expression of the GFP-fusion
protein.
With the method described above stable cell lines were
obtained that express a GFP-fusion from the ATR-Chk1
pathway, namely, ATRIP, Rad17, Rad9, Rad1, Hus1, and
Chk1 (Figure 1(c) and data not shown). We also generated
control cell lines expressing GFP and H2B-GFP-Chk1.
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3.1.8. Validation and Characterization of the Selected Stable
Cell Lines. To validate the functionality of the GFP-fusion
protein and characterize the stable cell lines we utilized a
number of assays.
Immunoprecipitations (IP) of the GFP-fusion protein
were performed to confirm the interaction of the GFP-fusion
with its known endogenous protein partners. We published
before that GFP-Rad9 interacts with its endogenous partners
Rad1 and Hus1 [33]. A similar experiment was performed
with GFP-ATRIP, which demonstrated that the GFP-fusion
was able to bind endogenous ATR (Figure 2(a)).
To check if stable expression of the GFP-fusion protein
influences the cells response to DNA damage by functioning
as a dominant negative, we determined the sensitivity of
our cell lines to genotoxic stress. We compared the colony
survival in response to UV light of the stable clones to the
parental untransfected cell line. As shown in Figure 2(b), the
expression of the GFP-Rad9 in both Hela and U2OS cells
did not alter the sensitivity to UV damage, indicating that
GFP-Rad9 does not function as a dominant negative. The
expression of GFP alone in Hela cells also did not influence
sensitivity to UV-irradiation.
The ATR-dependent checkpoint pathway is triggered in
response to genotoxic stress and induces the ATR-mediated
phosphorylation of Chk1, which results in a temporal cell
cycle arrest [11]. To test if expression of the GFP-fusion pro-
teins influences checkpoint activation we monitored the UV-
induced phosphorylation of Chk1. Expression of GFP-ATRIP
and GFP-Chk1 did not influence the levels of phosphorylated
Chk1 (Figure 2(c)). GFP-Chk1 is phosphorylated in response
to UV damage, indicating the GFP-tagged Chk1 behaves
similarly to the endogenous one. To study the G2 phase
arrest induced by DNA damage, we determined the mitotic
index of cells expressing GFP-Chk1 and untransfected cells.
A similar decrease in mitotic cells upon ionizing radiation
(IR) was observed in GFP-Chk1 expressing and control
cells, indicating that expression of GFP-Chk1 does not
interfere with the DNA damage-induced G2 checkpoint
(Figure 2(d)).
Although these assays demonstrate the absence of a
dominant negative eﬀect of the GFP-fusions, to definitively
rule out problems due to GFP-tagging, complementation of
a mutant or knock out cell line is required. Cells derived from
Seckel syndrome patients that harbour a mutation in the ATR
gene, leading to an abrogated expression of the ATR protein,
are available [43], but most proteins in this pathway are
essential for cell viability making a direct complementation
impossible in human cells. In addition, knock outs of Rad9
and Hus1 in mouse embryonic stem cells are lethal, although
the lethality of Hus1 disruption can be rescued by knocking
out p21 [44–46]. Chicken DT40 cells can be successfully
used for knocking out genes that are essential in mammalian
cells, like Chk1, but are less suitable for the generation of
stable GFP-fusion cell lines and live cell imaging, since these
cells are genomically unstable and can only be cultured
in suspension [47]. Another approach is siRNA-mediated
downregulation of the endogenous protein and subsequent
complementation by expression of the GFP-tagged protein.
We favour this option since in this way we are able to study
both the functionality of the GFP-fusion protein as well as its
mobility in the same cell line.
To specifically downregulate the endogenous protein, dif-
ferent siRNA-mediated approaches are available. First, as the
cDNA encoding for the GFP-fusion protein does not contain
a 3′UTR, the use of siRNA oligos that specifically target this
region of the protein of interest should result in knock down
of the endogenous protein only. We applied this approach
in cells expressing GFP-Rad9. Figure 2(e) demonstrates that
48 hours after transfection with siRNA oligo number 1,
endogenous Rad9 is more eﬃciently downregulated than the
GFP-labelled Rad9 protein. At 72 hours after transfection,
the eﬃciency of downregulation became less, demonstrating
that knock down is optimal 48 hours after transfection
with siRNA oligo number 1. Transfection with siRNA oligo
number 2 also lowered endogenous Rad9 levels more than
the GFP-labelled Rad9 protein levels and the eﬃciency of
downregulation was similar between 48 and 72 hours after
transfection. In an alternative approach, a silent mutation is
made in the cDNA of the GFP-tagged protein, thereby leaving
the encoded protein unchanged. By using siRNA oligos that
recognize the mRNA from the endogenous but not the GFP-
fusion protein, the endogenous protein can be specifically
downregulated, such that the functionality of the GFP-fusion
protein can be assessed [33]. Collectively the performed
validation assays indicate that the introduction and stable
expression of GFP-fusions of Chk1, ATRIP, Rad9, Rad1, and
Hus1 did not change the response of these cells to DNA
damage. These GFP-fusion proteins can therefore be seen as
functional equivalents of their endogenous counterparts.
3.2. Cellular Localization of GFP-Fusion Proteins in Response
to DNA Damage. Numerous studies over the past years
indicated that the accumulation of DNA damage response
proteins at sites of damage is of crucial importance for
downstream checkpoint events [14, 22, 24, 48, 49]. Although
for many proteins involved in checkpoint regulation a
(relatively small) fraction of the total pool of proteins is
bound to chromatin in unperturbed cells, the majority of
these proteins relocalize and accumulate at or near sites
of DNA lesions to form so-called nuclear foci [50]. GFP-
Rad9, for example, localizes into foci after the treatment with
diﬀerent DNA damaging agents (Figure 3(a)).
To investigate the specific DNA substrate onto which a
protein is recruited, diﬀerent DNA damaging agents can be
tested, as well as colocalization with other proteins involved
in the DNA damage response. Biochemical experiments
indicated that the Rad17-RFC and ATRIP-ATR protein
complexes are recruited to DNA damage-induced RPA-
coated ssDNA and this localization induces the activation of
the downstream kinase Chk1 [4, 51, 52]. Rad9, a component
of the 9-1-1 complex, is loaded onto the DNA by Rad17-
RFC in response to DNA damage [5, 53]. We observed
colocalization of GFP-Rad9 and RPA upon treatment of
cells with both UV light and IR, suggesting that Rad9 is
recruited to sites of RPA-coated ssDNA (Figure 3(a)). In
response to DNA damage, histone H2AX is phosphorylated
at Ser139 by ATM/ATR [54]. Although phosphorylation
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of H2AX (γH2AX) is commonly used to identify DSBs,
γH2AX is also induced in response to UV light or treatment
with other agents that do not directly induce DSBs, like
the replication inhibitor aphidicolin (Figure 3(a)) [55]. We
observed colocalization of GFP-Rad9 and γH2AX in all UV-
induced foci whereas treatment of cells with aphidicolin
or IR did not result in a complete colocalization of the
two proteins (Figure 3(a) and data not shown). Close
inspection demonstrated that foci induced by aphidicolin
either contained both GFP-Rad9 and γH2AX or γH2AX only.
Since the phosphorylation of H2AX is triggered in response
to a wide variety of DNA lesions, we conclude that GFP-Rad9
is only recruited to a subset of aphidicolin-induced DNA
lesions.
Not all proteins accumulate into foci, even though they
are recruited to sites of DNA damage. Proteins involved in
nucleotide excision repair, for example, do not form foci
in response to genotoxic stress. The accumulation of these
proteins onto damaged DNA can be visualized by applying
local UV damage in the nucleus. By irradiating the cells
while covered with an isopore filter, the UV light can only
penetrate the pores and as a consequence, only a small
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part(s) of the nucleus contains damaged DNA [56, 57].
As shown in Figure 3(b), proteins involved in the ATR-
mediated checkpoint pathway, such as Rad9, also accumulate
onto local UV damage. This method requires fixation of
cells and is therefore unsuitable for live cell imaging. The
development of laser-induced DNA damage circumvented
this problem [26, 36, 58]. Laser-induced DNA damage can be
easily combined with live cell imaging and diﬀerent types of
lasers are commonly available [15, 59]. For example, recent
studies make use of specific types of sources and lasers,
specifically inducing subsets of DNA lesions such as CPDs
and 6-4P induced by UV light, and DSBs [14, 36, 56, 60, 61].
Nonetheless caution is required, as often sources and lasers
also produce other, unwanted, types of lesions, that may
influence protein behaviour adversely [36, 62].
We did not observe the accumulation of the eﬀector
kinase Chk1 into nuclear foci in response to DNA damage
nor onto locally applied UV-induced DNA damage using a
filter (data not shown), in contrast to ATR, TopBP1, 9-1-
1 members, and many other checkpoint mediator proteins.
In this sense, Chk1 behaves similarly to Chk2, the eﬀector
kinase for the cellular response to DSBs [15]. In order to
trigger a cell cycle arrest in response to DNA damage, these
eﬀector kinases phosphorylate a range of substrates that are
present throughout the nucleus. Although both Chk1 and
Chk2 do not associate to chromatin after DNA damage, Chk1
associates to chromatin in unperturbed cells and is released
from the chromatin in response to DNA damage [35]. In the
light of this, the absence of accumulated Chk1 at sites of DNA
lesions was to be expected.
3.3. Quantitative GFP-Fusion Protein Dynamics. By measur-
ing the change in mobility of a protein in response to DNA
damage a number of parameters can be determined. First,
the time the protein spends at the site of a DNA lesion
and second, the fraction of the total amount of protein
engaged in that process. Fluorescent Redistribution after
Photobleaching (FRAP) is applied to study the mobility of
GFP-fusion proteins in living cells. In a defined region (strip)
of the nucleus, the fluorescence is irreversibly photobleached
through brief illumination at high laser intensity (strip-
FRAP). Redistribution or recovery of the total fluorescence
in the bleached area is then measured in time, indicative of
protein mobility [16, 63, 64].
To gain further understanding of how the proteins
in the ATR-pathway sense DNA lesions and subsequently
respond to trigger the checkpoint-mediated cell cycle arrest,
the dynamic behaviour of these proteins was studied. We
demonstrated that GFP-Rad1, GFP-ATRIP, and GFP-Rad9
form foci and are recruited to chromatin in response to DNA
damage, as shown by chromatin fractionation (Figure 4(a),
data not shown) [21]. To address whether these proteins
become immobilized at sites of DNA lesions, we determined
the change in mobility of GFP-Rad1, GFP-Rad9, Hus1-
GFP, and GFP-ATRIP upon UV-irradiation. Importantly, the
total amount of GFP-labelled molecules could be diﬀerent
between cells and between GFP-fusion protein cell lines.
These two discrepancies could potentially influence photo-
bleaching results since relative immobilization is dependent
on the total amount of protein available. To adjust for cell-to-
cell diﬀerences in a population, we normalized the obtained
measurements as described in Section 2. Furthermore, we
used saturating amounts of UV-irradiation to be sure that
all possible molecules would be engaged (data not shown).
Although we did not measure the exact amount of GFP-
fusion molecules per cell, western blotting analysis indicates
that the diﬀerent GFP-fusion proteins are expressed to a
similar extent (Figure 1(b)).
In response to UV light, 20%–40% of the 9-1-1 complex
proteins become immobilized (Figures 4(b)–4(e)). The GFP-
Rad1 and Hus1-GFP FRAP curves show more variability
compared to the GFP-Rad9 FRAP curve, which is probably
due to the fluorescent variety of the GFP-Rad1 and Hus1-
GFP cell lines and the amount of cells that were measured
(Figures 4(b)–4(d)). Although the ATRIP-ATR complex is
also recruited to sites of DNA damage, relatively less GFP-
ATRIP is immobilized (5%–10%) in response to UV damage
as compared to either of the proteins of the 9-1-1 complex
(Figure 4(e)). These data demonstrate that the 9-1-1 and
ATRIP-ATR complexes behave diﬀerently after DNA damage
and suggest that ATRIP displays a higher turnover at sites of
DNA lesions.
To further investigate the possible distinct behaviour
between these two putative DNA damage sensor complexes
Fluorescent Loss after photobleaching (FLIP) experiments
were performed. During FLIP half of the nucleus is
constantly bleached and the loss of fluorescence in the
unbleached half of the nucleus is measured, representing the
rate of dissociation. As shown in Figure 4(f), nondamaged
cells expressing either GFP-Rad9 or GFP-ATRIP completely
lost fluorescence 150 seconds after start of bleaching (k1/2∼
15 seconds). After UV irradiation the dissociation rates
were less fast. GFP-ATRIP completely lost fluorescence after
250 seconds (k1/2 ∼ 25 seconds) whereas GFP-Rad9 after
more than 300 seconds (k1/2∼ 40 seconds). These FLIP
experiments indicate that after DNA damage induction
both ATRIP and Rad9 become less mobile, but the release
(dissociation) of ATRIP from sites of damage is faster than
Rad9. These data are in accordance to the FRAP experi-
ments, that show relatively less immobilization of ATRIP
upon UV irradiation as compared to the proteins of the
9-1-1 complex.
The rate at which proteins associate to sites of DNA
lesions was addressed by measuring the accumulation of
proteins upon local UV laser irradiation. Briefly, a small
area inside the nucleus is irradiated with a 266 nm UV
laser. GFP-Rad9 and GFP-ATRIP fluorescence in the locally
damaged area was measured every 60 seconds until a plateau
was reached. GFP-ATRIP quickly started accumulating at
the damaged area and reaches a plateau ∼20 minutes
after damage induction (k1/2∼ 6 minutes) (Figure 4(g)).
GFP-Rad9 accumulation in the first 8 minutes is relatively
slow, but rises faster thereafter and reaches a plateau
after ∼30 minutes (k 1/2 ∼ 12 minutes) (Figure 4(g)).
These results indicate that ATRIP and Rad9 associate
very diﬀerently to UV-damaged DNA and suggest that
ATRIP is recruited directly to the sites of damage in an
exponential manner, following Michaelis-Menten kinetics
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Figure 4: UV-induced changes in mobility of checkpoint proteins. (a) U2OS cells expressing GFP-ATRIP (left panel) and GFP-Rad1 (right
panel) were left untreated or treated with UV. Two hours later, soluble and chromatin-bound proteins were isolated and analyzed by western
blotting using the indicated antibodies. (b–e) Hus1-GFP (b), GFP-Rad1 (c), GFP-Rad9 (d), and GFP-ATRIP (e) expressing cells were left
untreated or treated with UV and analyzed by strip-FRAP (see Section 2 for technical details). (f) U2OS cells expressing GFP-Rad9 or GFP-
ATRIP were left untreated or treated with UV. After 1 hour cells were analyzed by FLIP (see Section 2 for technical details). Plotted is the loss
of fluorescence during continuous bleaching. (g) U2OS cells expressing GFP-Rad9 or GFP-ATRIP were locally irradiated using a 266 nm UV
laser. Plotted is the association of fluorescent signal at the locally damaged area.
[65] whereas the accumulation kinetics of Rad9 follow a
sigmoidal curve (non-Michaelis-Menten kinetics), repre-
senting cooperative binding [66]. Rad17-dependent loading
of Rad9 onto the DNA might explain this cooperative
binding of GFP-Rad9 after DNA damage induction [67],
compared to ATRIP-ATR which binds directly to RPA-coated
ssDNA [4].
Chk1 is phosphorylated at or near the DNA lesion and
thereafter released from the chromatin [35] and conse-
quently, the amount of immobilized GFP-Chk1 measured by
photobleaching experiments might become lower after DNA
damage induction. To test this hypothesis, we performed
strip-FRAP on cells expressing GFP-Chk1 treated with UV
light. We compared the GFP-Chk1 mobility with that of
free GFP and an artificially immobile form of Chk1, where
GFP-Chk1 was fused to histone H2B (H2B-GFP-Chk1)
[35]. Upon photobleaching GFP-Chk1 demonstrated a fast
recovery of fluorescence both before and after UV damage
(Figure 5(a)). The recovery was similar to that of free GFP,
arguing against the existence of a stably bound GFP-Chk1
fraction. Since GFP-Chk1 was present in relatively high
levels due to overexpression in addition to endogenous
Chk1, we reasoned that the amount of Chk1 might be
too high to observe any change in protein mobility upon
DNA damage induction. Therefore, we lowered the total
amount of Chk1 by RNA interference. Cells expressing GFP-
Chk1 were transfected with either control luciferase or Chk1
siRNA oligos. Twenty four hours later cells were treated with
UV light and chromatin fractions were prepared. As shown
in Figure 5(b), both endogenous and GFP-labelled Chkl
were released from chromatin upon DNA damage induction
in control downregulated cells, although the GFP-tagged
version less eﬃciently than endogenous Chk1 (endogenous
64%, GFP-labelled 16%). Transfection of Chk1 siRNA oligos
resulted in downregulation of endogenous Chk1 and did
not influence the release of Chk1 from chromatin. Although
GFP-Chk1 is less eﬃciently released from the chromatin
than endogenous Chk1, a small but considerable fraction of
GFP-Chk1 (∼15%) is released in response to DNA damage,
which is comparable to the previous experiment without the
depletion of endogenous Chk1.
Next, we lowered the total amount of Chk1 in GFP-Chk1
expressing cells by siRNA-mediated downregulation. Subse-
quent strip-FRAP analysis indicated that nondamaged GFP-
Chk1 expressing cells did not contain more immobile GFP-
Chk1 molecules compared to UV-treated cells (Figure 5(c)).
Downregulation of Chk1 did not influence the recovery
of residual GFP-Chk1 fluorescence in untreated cells and
accordingly it did not change GFP-Chk1 mobility after UV-
treatment.
The strip-FRAP experiments demonstrated the absence
of a stably bound Chk1 pool in these conditions. Nonethe-
less, these experiments were performed in a relatively short
period of time (20 seconds). Since Chk1 released from
the chromatin in response to UV-induced DNA damage
could be a more gradual and thus time-dependent process,
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Figure 5: Mobility of GFP-Chk1 in response to DNA damage. (a) U2OS cells expressing GFP, H2B-GFP-Chk1, or GFP-Chk1 were left
untreated or treated with UV and analyzed by strip-FRAP (see Section 2 for technical details). (b) Chromatin fractionation of GFP-Chk1
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we additionally addressed GFP-Chk1 mobility by determin-
ing its residence time on DNA. Chk1 was downregulated in
GFP-Chk1 expressing cells as previously described and sub-
sequently the cells were irradiated with UV-light. Thereafter,
half of the nucleus was bleached once and redistribution of
GFP-Chk1 fluorescence was measured in the bleached and
unbleached area over time. The time it takes to reach full
fluorescent redistribution determines the proteins residence
time. The results shown in Figure 5(d) indicated that GFP-
Chk1 reached redistribution after 40 seconds, which is
outside the timeframe of our original experiment. However,
during the 40 seconds directly after bleaching we did not
observe any diﬀerence in the mobility using this method.
These results further indicate that Chk1 is a highly mobile
protein and suggests that it only very transiently interacts
with the chromatin.
4. Discussion
The initial response to DNA damage is of crucial importance
for cell functioning and viability, since an improper DNA
damage response can eventually lead to cancer and other
human diseases [1, 68]. In response to UV light, the putative
DNA sensors Rad17-RFC and ATRIP-ATR are independently
recruited to DNA regions containing RPA-coated ssDNA
[4, 52]. Rad17-RFC is responsible for the loading of the 9-
1-1 complex onto the DNA [5]. These events are required
for the subsequent activation of Chk1, which results in a cell
cycle arrest [12]. To gain further insight into the events that
take place after a genotoxic insult in living cells, we GFP-
labelled several proteins of the ATR pathway and expressed
these fusion proteins in human cells. We discussed how to
generate and validate stable GFP-fusion cell lines.
The quantitative analysis of GFP-fusion proteins in living
cells using video microscopy allowed us to determine the
dynamic behaviour of diﬀerent individual proteins of the
pathway in response to DNA damage. With the use of
photobleaching techniques (strip-FRAP, FLIP, FLIP-FRAP,
local UV laser) we determined multiple parameters of the
proteins, including the rate of accumulation onto locally
induced UV laser damage, rate of diﬀusion, immobile
fraction, and the average time of immobilization (residence
time) before and after global UV-irradiation. These methods
are useful tools to investigate the dynamics of proteins
involved in the DNA damage response, as shown in this
paper, since many of the involved proteins bind DNA
or proteins present at the site of damage and become
immobilized to a certain extent.
GFP-Rad9, GFP-Rad1, Hus1-GFP, and GFP-ATRIP accu-
mulate into nuclear foci in response to DNA damage.
However, a relatively larger fraction of the 9-1-1 complex
proteins become immobilized in response to UV as com-
pared to ATRIP. Biochemical experiments show that the 9-
1-1 complex is loaded onto the 5′ ssDNA/dsDNA by Rad17-
RFC, therefore, its association to DNA lesions might take
some time and is the result of cooperative binding [51]. In
contrast, ATRIP interacts directly with RPA-coated ssDNA,
explaining its exponential binding behaviour [4]. The results
obtained by FLIP suggest that a loaded 9-1-1 complex
cannot easily dissociate from the DNA. This dissociation
might be slower because the 9-1-1 complex forms a ring
around the DNA. It, therefore, has to either slide oﬀ a
DNA end or actively dissociate, which likely is a more time-
consuming process [69]. In addition, the FRAP experiments
show that 20%–40% of the 9-1-1 complex molecules become
immobile whereas only 5%–10% of the ATRIP molecules is
immobilized after DNA damage. These results also indicate a
relatively more stable association of the 9-1-1 complex with
damaged chromatin which is consistent with the FLIP results.
All together, the putative DNA damage sensors Rad9-
Rad1-Hus1 and ATRIP-ATR show a diﬀerent dynamic
behaviour directly after induction and during the presence
of UV-induced DNA damage. Nonetheless, both GFP-Rad9
and GFP-ATRIP molecules are exchanging rapidly in UV-
induced foci since all the mobility measurements performed
on both GFP-Rad9 and GFP-ATRIP DNA damage-induced-
foci do not indicate a stable immobilized fraction, suggesting
that these foci are not static but highly dynamic structures.
Recruitment of the ATRIP-ATR heterodimer to sites of
DNA damage results in ATR kinase activation which leads
to the phosphorylation and subsequent activation of the
Chk1 kinase [70, 71]. To investigate the spatio and temporal
behaviour of downstream eﬀector Chk1 in living cells, we
studied the dynamic behaviour of GFP-Chk1 in response
to DNA damage. In vivo imaging experiments confirm the
absence of a stable chromatin-bound Chk1 fraction. The
data presented here signify that Chk1 is a very mobile
protein both in the absence or presence of DNA damage.
The observed chromatin binding of Chk1 that is observed
in biochemical experiments is not indicative of a stably
bound Chk1 chromatin fraction [35] (Figure 5(b)). This
high nuclear mobility of Chk1 was hypothesized to ensure
the access of additional Chk1 molecules to ATR and the
transmission of the damage signal throughout the nucleus
[15, 35, 72].
Measuring protein mobility is not always as straight-
forward as it seems. Problems that are commonly faced
when performing these types of experiments are monitor
bleaching, influx of proteins from the cytoplasm, and
blinking. Monitor bleaching is caused by observing the
cells before, during, and after photobleaching or time lapse
experiments. By using low amounts of laser power this can
be avoided, although with low fluorescent protein levels
this could be problematic. Lowering the laser power could
result in a low resolution, which in turn results in a large
variability between measurements. Monitor bleaching can
be corrected for by measuring the amount of bleaching
in an unbleached area of the cell, but this only applies
for freely diﬀusion proteins [63, 73]. Another potential
problem is the presence of a cytoplasmic protein fraction
that could influence nuclear measurements due through
the influx of fluorescence from the cytoplasm. Before the
start of the actual measurement, the cytoplasmic fraction
can be bleached, thereby eliminating this potential influx.
Blinking is the property of fluorescent molecules to be
reactivated, which can also influence photobleaching results.
By keeping experimental conditions similar in all conditions
the influence of blinking is constant in all measurements and,
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therefore, insignificant. When comparing results obtained
from diﬀerent fluorescent variants, on the other hand, it
needs to be taken into account that the blinking properties
are diﬀerent and, therefore, the amount of blinking needs to
be determined for every variant and corrected for in the final
analysis [63, 73].
To overcome the problem of GFP-fusion protein overex-
pression and the (competitive) presence of the endogenous
counterpart, a GFP knock-in strategy using mice can be
utilized [74] (Jeroen Essers, personal communication). This
method places the GFP tag before the endogenous gene
of interest in the mice genome, thereby being regulated
by the endogenous promoter. As a result the expression
levels of the GFP-fusion protein are identical to nontargeted
protein in wild type cells, resulting in better quantitative
measurements. The behaviour of proteins can additionally be
studied in diﬀerent tissues and cell types under physiological
conditions [75]. Performing a similar approach for proteins
involved in the ATR-Chk1 pathway may result in a more
precise determination of the dynamic behaviour of this DNA
damage checkpoint pathway. The ATR gene may act as a good
candidate to start a GFP knock in approach, since it localizes
to sites of damage and thereby becomes immobilized. Fur-
thermore, ATR interacts with and phosphorylates a number
of key target proteins.
Conclusively, we show that the GFP-labelling of ATRIP,
Chk1, and the 9-1-1 complex proteins results in functional
equivalents that can be studied by live cell video microscopy
and quantitative fluorescence photobleaching. We compared
the mobility changes of GFP-ATRIP, GFP-Chk1, GFP-Rad9,
GFP-Rad1, and Hus1-GFP after UV-irradiation and col-
lectively the results indicate a distinct dynamic behaviour
between some of the studied proteins. Whereas eﬀector
kinase Chk1 is highly mobile and does not immobilize upon
DNA damage, Rad9 and ATRIP stably associate to sites of
DNA lesions. ATRIP directly binds to DNA lesions but more
transiently than Rad9, which in contrast displays a more
stable association with damaged chromatin. Together these
data demonstrate the importance of spatio and temporal
protein regulation in the DNA damage-induced ATR-Chk1
pathway.
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